Caliper Technologies Corp
This article was originally published in The Gray Sheet
Initial public offering of 4.5 mil. shares at $16 each grosses $72 mil. Larger than the previously anticipated 3.6 mil. shares at $13-15 each, the IPO will help fund scale-up of manufacturing operations for initial LabChip "lab-on-a-chip" technologies and further R&D activities (1"The Gray Sheet" Dec. 6, p. 16). The Mountain View, California firm's stock is trading under the symbol "CALP," and not "CLPR" as expected earlier. Credit Suisse First Boston, CIBC World Markets Corp. and Hambrecht & Quist LLC were underwriters for the offering
You may also be interested in...
Development of "lab-on-a-chip" technologies used in high-throughput nucleic acid analysis for diagnostics applications is one of several development projects that would benefit from Caliper Technologies' $46 mil. initial public offering.
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.